Header

UZH-Logo

Maintenance Infos

Injection drug use and the hepatitis C virus: considerations for a targeted treatment Approach - the case study of Canada


Fischer, B; Haydon, E; Rehm, J; Krajden, M; Reimer, J (2004). Injection drug use and the hepatitis C virus: considerations for a targeted treatment Approach - the case study of Canada. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(03):428-447.

Abstract

Infection with the hepatitis C virus (HCV) is a major public health burden in Canada and globally. The literature shows that injection drug use is currently the primary transmission route for HCV, and that a majority of injection drug users (IDUs) are currently infected with HCV in Canada. This article first reviews the burden of HCV within IDU populations and the transmission risks and the treatment implications specific to IDUs. Traditionally, IDUs have been excluded from HCV treatment unless abstaining from illicit drug use. However, recent research suggests that categorical exclusion is not medically necessary. A series of key questions about the feasibility of offering HCV treatment to IDUs in the specific Canadian context are considered, including concerns related to the motivation of treatment for IDUs, treatment delivery, treatment side effects, HCV reinfection, and the social environment. The article concludes that treatment of HCV-infected illicit drug users is both feasible and may be necessary to reduce transmission and adverse outcomes in this high-risk population

Abstract

Infection with the hepatitis C virus (HCV) is a major public health burden in Canada and globally. The literature shows that injection drug use is currently the primary transmission route for HCV, and that a majority of injection drug users (IDUs) are currently infected with HCV in Canada. This article first reviews the burden of HCV within IDU populations and the transmission risks and the treatment implications specific to IDUs. Traditionally, IDUs have been excluded from HCV treatment unless abstaining from illicit drug use. However, recent research suggests that categorical exclusion is not medically necessary. A series of key questions about the feasibility of offering HCV treatment to IDUs in the specific Canadian context are considered, including concerns related to the motivation of treatment for IDUs, treatment delivery, treatment side effects, HCV reinfection, and the social environment. The article concludes that treatment of HCV-infected illicit drug users is both feasible and may be necessary to reduce transmission and adverse outcomes in this high-risk population

Statistics

Citations

37 citations in Web of Science®
40 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Swiss Research Institute for Public Health and Addiction
Dewey Decimal Classification:610 Medicine & health
Uncontrolled Keywords:Canada;Comorbidity;Environment;Hepatitis C;Humans;IDU;Infection;Intravenous;Motivation;Ontario;Prostitution;Public Health;Recurrence;Research;Risk;Risk Assessment;Risk Factors;Social Environment;Substance Abuse;Therapy;Transmission;drug;drug use;epidemiology;health;hepatitis;illicit drug use;review;treatment;use
Language:English
Date:2004
Deposited On:30 Jul 2014 14:41
Last Modified:05 Apr 2016 17:59
Publisher:Springer
ISSN:1099-3460
Publisher DOI:https://doi.org/10.1093/jurban/jth128

Download

Full text not available from this repository.
View at publisher